Showing results (711-720 of 1,361) with videos related to
Sort By:
Pageof 137
Oncogene|December 17, 1997
Reexpression of the retinoblastoma protein in tumor cells induces senescence and telomerase inhibitionH J Xu, Y Zhou, W Ji, et al.Seminars in Oncology|November 14, 2001
The role of genetic abnormalities of PTEN and the phosphatidylinositol 3-kinase pathway in breast and ovarian tumorigenesis, prognosis, and therapyG B Mills, Y Lu, X Fang, et al.British Journal of Cancer|September 25, 2008
A novel AKT3 mutation in melanoma tumours and cell linesM A Davies, K Stemke-Hale, C Tellez, et al.Discovery Medicine|February 19, 2014
Implementation of biomarker-driven cancer therapy: existing tools and remaining gapsAnn M Bailey, Yong Mao, Jia Zeng, et al.International Journal of Oncology|July 6, 2007
Lysophosphatidic acid induction of urokinase plasminogen activator secretion requires activation of the p38MAPK pathwayVeronica C Estrella, Astrid M Eder, Shuying Liu, et al.Molecular Cancer Therapeutics|March 21, 2006
Inhibition of Akt survival pathway by a small-molecule inhibitor in human glioblastomaDimpy Koul, Ruijun Shen, Sherry Bergh, et al.The Journal of Clinical Investigation|June 16, 2015
Death-associated protein kinase 1 promotes growth of p53-mutant cancersJing Zhao, Dekuang Zhao, Graham M Poage, et al.Annals of Neurology|August 28, 2007
An intriguing "silent" mutation and a founder effect in antiquitin (ALDH7A1)Gajja S Salomons, Levinus A Bok, Eduard A Struys, et al.Journal of the National Cancer Institute|June 18, 2010
Nicotinic acetylcholine receptor region on chromosome 15q25 and lung cancer risk among African Americans: a case-control studyChristopher I Amos, Ivan P Gorlov, Qiong Dong, et al.Oncogene|August 16, 2016
RCP induces Slug expression and cancer cell invasion by stabilizing β1 integrinM H Hwang, K H Cho, K J Jeong, et al.Pageof 137